Prevention of Anthracycline-induced Cardiotoxicity

NCT01968200 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

268

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Enalapril

Sponsor

European Institute of Oncology